The application of anti-VEGF therapy has revolutionized the treatment for many retinal diseases [3], including age-related macular degeneration (AMD), diabetic retinopathy (DR), retinal vein occlusion (RVO), retinopathy of prematurity (ROP) [4]. The gene discussed is VEGFA; the disease is retinopathy of prematurity.